BACKGROUND: Patients on oral anticoagulant therapy (OAT) require regular testing of the prothrombin time (PT) and the international normalised ratio (INR) to monitor their blood coagulation level to avoid complications of either over or under coagulation. PT/INR can be tested by a healthcare professional or by the patient. The latter mode of the testing is known as patient self-testing or home testing. The objective of this study was to elicit patients' perspectives and experiences regarding PT/INR self-testing using portable coagulometer devices. METHODS: Internet blog text mining was used to collect 246 blog postings by 108 patients, mainly from the USA and the UK. The content of these qualitative data were analysed using XSight and NVivo...
Clinical trials suggest that oral anticoagulation therapy (OAT) self-monitoring is safe and effectiv...
Background: Warfarin is the most commonly prescribed oral anticoagulant for the prevention and treat...
BACKGROUND: Trials show that oral anticoagulation therapy (OAT) substantially reduces thromboembolic...
Abstract Background Patients on oral anticoagulant therapy (OAT) require regular testing of the prot...
Purpose: The aim of this study was to know the patients’ point of view on the monitoring of vitamin ...
Syed Ghulam Sarwar Shah,1 Julie Barnett,1 Jasna Kuljis,2 Kate Hone,2 Richard Kaczmarski31Multidiscip...
Background: Technology assisted self-testing and management is seen as one of the key areas in whic...
BACKGROUND AND OBJECTIVES: Self-testing and self-monitoring with portable prothrombin time (PT) moni...
BACKGROUND AND OBJECTIVES: Self-testing and self-monitoring with portable prothrombin time (PT) moni...
Background Clinical trials suggest that oral anticoagulation therapy (OAT) self-monitoring is safe a...
Purpose: The aim of this study was to know the patients’ point of view on the monitoring of vitamin ...
Doris Barcellona, Diego Mastino, Francesco Marongiu Department of Medical Science and Public Health...
Background and Objectives. Self-testing and self-monitoring with portable prothrombin time (PT) moni...
Background and Objectives. Self-testing and self-monitoring with portable prothrombin time (PT) moni...
BACKGROUND: Clinical trials suggest that oral anticoagulation therapy (OAT) self-monitoring is safe ...
Clinical trials suggest that oral anticoagulation therapy (OAT) self-monitoring is safe and effectiv...
Background: Warfarin is the most commonly prescribed oral anticoagulant for the prevention and treat...
BACKGROUND: Trials show that oral anticoagulation therapy (OAT) substantially reduces thromboembolic...
Abstract Background Patients on oral anticoagulant therapy (OAT) require regular testing of the prot...
Purpose: The aim of this study was to know the patients’ point of view on the monitoring of vitamin ...
Syed Ghulam Sarwar Shah,1 Julie Barnett,1 Jasna Kuljis,2 Kate Hone,2 Richard Kaczmarski31Multidiscip...
Background: Technology assisted self-testing and management is seen as one of the key areas in whic...
BACKGROUND AND OBJECTIVES: Self-testing and self-monitoring with portable prothrombin time (PT) moni...
BACKGROUND AND OBJECTIVES: Self-testing and self-monitoring with portable prothrombin time (PT) moni...
Background Clinical trials suggest that oral anticoagulation therapy (OAT) self-monitoring is safe a...
Purpose: The aim of this study was to know the patients’ point of view on the monitoring of vitamin ...
Doris Barcellona, Diego Mastino, Francesco Marongiu Department of Medical Science and Public Health...
Background and Objectives. Self-testing and self-monitoring with portable prothrombin time (PT) moni...
Background and Objectives. Self-testing and self-monitoring with portable prothrombin time (PT) moni...
BACKGROUND: Clinical trials suggest that oral anticoagulation therapy (OAT) self-monitoring is safe ...
Clinical trials suggest that oral anticoagulation therapy (OAT) self-monitoring is safe and effectiv...
Background: Warfarin is the most commonly prescribed oral anticoagulant for the prevention and treat...
BACKGROUND: Trials show that oral anticoagulation therapy (OAT) substantially reduces thromboembolic...